These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 26768739)

  • 41. Role of Ivabradine in the Treatment of Patients With Cardiovascular Disease.
    Weeda ER; Nguyen E; White CM
    Ann Pharmacother; 2016 Jun; 50(6):475-85. PubMed ID: 26917820
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial.
    Böhm M; Swedberg K; Komajda M; Borer JS; Ford I; Dubost-Brama A; Lerebours G; Tavazzi L;
    Lancet; 2010 Sep; 376(9744):886-94. PubMed ID: 20801495
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ivabradine: A Review of Labeled and Off-Label Uses.
    Oliphant CS; Owens RE; Bolorunduro OB; Jha SK
    Am J Cardiovasc Drugs; 2016 Oct; 16(5):337-47. PubMed ID: 27405864
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effectiveness of Ivabradine Treatment in Different Subpopulations with Stable Angina in Clinical Practice: A Pooled Analysis of Observational Studies.
    Werdan K; Perings S; Köster R; Kelm M; Meinertz T; Stöckl G; Müller-Werdan U
    Cardiology; 2016; 135(3):141-150. PubMed ID: 27333284
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of ivabradine in patients with stable angina receiving β-blockers according to baseline heart rate: an analysis of the ASSOCIATE study.
    Tardif JC; Ponikowski P; Kahan T;
    Int J Cardiol; 2013 Sep; 168(2):789-94. PubMed ID: 23138014
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Use and Indication of Ivabradine in Heart Failure.
    Dodd K; Lampert BC
    Heart Fail Clin; 2018 Oct; 14(4):493-500. PubMed ID: 30266358
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Characterization of the heart rate-lowering action of ivabradine, a selective I(f) current inhibitor.
    Borer JS; Le Heuzey JY
    Am J Ther; 2008; 15(5):461-73. PubMed ID: 18806523
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial.
    Fox K; Ford I; Steg PG; Tendera M; Ferrari R;
    Lancet; 2008 Sep; 372(9641):807-16. PubMed ID: 18757088
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of the SIGNIFY trial.
    Grassi G
    Expert Opin Pharmacother; 2015; 16(12):1861-4. PubMed ID: 26153241
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of ivabradine-induced heart rate reduction on flow-mediated dilation measured with high-sensitivity ultrasound in patients with stable coronary heart disease.
    Jochmann N; Schröter F; Knebel F; Hättasch R; Gericke C; Stangl K; Baumann G; Stangl V
    Cardiovasc Ultrasound; 2014 Jan; 12():5. PubMed ID: 24479706
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacological Management of Chronic Stable Angina: Focus on Ranolazine.
    Rosano GMC; Vitale C; Volterrani M
    Cardiovasc Drugs Ther; 2016 Aug; 30(4):393-398. PubMed ID: 27417323
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Safety of ivabradine in patients with coronary artery disease and left ventricular systolic dysfunction (from the BEAUTIFUL Holter Substudy).
    Tendera M; Talajic M; Robertson M; Tardif JC; Ferrari R; Ford I; Steg PG; Fox K;
    Am J Cardiol; 2011 Mar; 107(6):805-11. PubMed ID: 21247517
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Frequency of angina and quality of life in outpatients with stable coronary artery disease in Turkey: insights from the PULSE study.
    Akyildiz ZI; Ergene O;
    Acta Cardiol; 2014 Jun; 69(3):253-9. PubMed ID: 25029869
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ivabradine in Coronary Heart Disease-The Emperor Has No Clothes.
    Messerli FH; Rimoldi SF; Bangalore S
    Am J Cardiol; 2017 Aug; 120(3):e15. PubMed ID: 27349902
    [No Abstract]   [Full Text] [Related]  

  • 55. Ivabradine: an intelligent drug for the treatment of ischemic heart disease.
    Riccioni G
    Molecules; 2012 Nov; 17(11):13592-604. PubMed ID: 23159921
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study.
    Swedberg K; Komajda M; Böhm M; Borer JS; Ford I; Dubost-Brama A; Lerebours G; Tavazzi L;
    Lancet; 2010 Sep; 376(9744):875-85. PubMed ID: 20801500
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role of the Funny Current Inhibitor Ivabradine in Cardiac Pharmacotherapy: A Systematic Review.
    Petite SE; Bishop BM; Mauro VF
    Am J Ther; 2018; 25(2):e247-e266. PubMed ID: 26910057
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Influence of Cardiovascular and Noncardiovascular Co-morbidities on Outcomes and Treatment Effect of Heart Rate Reduction With Ivabradine in Stable Heart Failure (from the SHIFT Trial).
    Böhm M; Robertson M; Ford I; Borer JS; Komajda M; Kindermann I; Maack C; Lainscak M; Swedberg K; Tavazzi L
    Am J Cardiol; 2015 Dec; 116(12):1890-7. PubMed ID: 26508709
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Quality of Life With Ivabradine in Patients With Angina Pectoris: The Study Assessing the Morbidity-Mortality Benefits of the If Inhibitor Ivabradine in Patients With Coronary Artery Disease Quality of Life Substudy.
    Tendera M; Chassany O; Ferrari R; Ford I; Steg PG; Tardif JC; Fox K;
    Circ Cardiovasc Qual Outcomes; 2016 Jan; 9(1):31-8. PubMed ID: 26696613
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effect of heart rate reduction by ivabradine on collateral function in patients with chronic stable coronary artery disease.
    Gloekler S; Traupe T; Stoller M; Schild D; Steck H; Khattab A; Vogel R; Seiler C
    Heart; 2014 Jan; 100(2):160-6. PubMed ID: 24186565
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.